Vegan Collagen
VeCollal®
VeCollal® is a plant-based biomimetic ingredient designed to mimic the amino acid profile of human type I collagen.
What is VeCollal®?
VeCollal® is TCI's proprietary plant-based biomimetic collagen ingredient made from non-GMO, plant-derived ingredients. Designed to mimic the amino acid composition of human type I collagen, it combines Vitamin C, Centella asiatica extract, and Panax ginseng extract.
Benefits of VeCollal®
Awards
Scientific Publication
A double-blind, placebo-controlled study on oral supplementation of vegan collagen biomimetic.[1]
Available Dosage Forms
Reference
- Lin, Y.-K., Liang, C.-H., Lin, Y.-H., Lin, T.-W., Vázquez, J. J., van Campen, A., & Chiang, C.-F. (2024). Oral supplementation of vegan collagen biomimetic has beneficial effects on human skin physiology: A double-blind, placebo-controlled study. Journal of Functional Foods, 113, 105955.
Frequently Asked Questions
No. VeCollal® is a plant-based biomimetic collagen ingredient designed to mimic the composition of human type I collagen and support the body's natural collagen production, rather than supplying animal-derived collagen.
The mechanism described is the ingredient's design intent, not a substantiated finished-product effect; the claims a product can use depend on the complete formula and target-market regulations.
Yes. VeCollal® is made entirely from non-GMO, plant-derived ingredients and contains no animal-derived components, making it suitable for plant-based product development.
VeCollal® can be considered for beauty-from-within product concepts.
Suitability here reflects the directions a product can be developed toward, not substantiated efficacy; the groups a finished product may address depend on its complete formula and local regulations.
Yes. VeCollal® has been evaluated in an 8-week randomized, controlled clinical trial in 90 participants; the outcome measures and study conditions are set out in the published paper.
These results were obtained under the specific conditions of that trial and are not equivalent to the effects of a finished product containing the ingredient.
The human clinical study evaluated 5 g of VeCollal® per day. One serving daily for eight weeks demonstrated significant improvements in multiple skin health parameters.
5 g daily is the trial condition rather than a recommended intake; a finished product's serving size depends on its formula, format and the regulations of the market where it is sold.